|
Biological Activity:
Subtype selective partial agonist at GABAA receptor, showing significant efficacy at α3; nonbenzodiazepine anxiolytic
References: online 1
R Dias et al. Evidence for a Significant Role of α3-Containing GABAA Receptors in Mediating the Anxiolytic Effects of Benzodiazepines. J. Neurosci. 2005, 25(46), 10682–10688.
RL Fradley et al. Differential contribution of GABA(A) receptor subtypes to the anticonvulsant efficacy of benzodiazepine site ligands. J. Psychopharmacol. 2007, 4, 384-391. [abstract]
W Sieghart. GABAA receptors as targets for different classes of drugs. Drugs Fut. 2006, 31(8), 685. [abstract]
J Knabl etal. Reversal of pathological pain through specific spinal GABAA receptor subtypes. Nature 2008, 451, 330-334. [abstract] [f1000medicine]
Chemical Name: 4,2'-Difluoro-5'-[8-fluoro-7-(1-hydroxy-1-methylethyl)imidazo[1,2-a]pyridin-3-yl]biphenyl-2-carbonitrile
|